Pamela Bartels

969 total citations
10 papers, 740 citations indexed

About

Pamela Bartels is a scholar working on Hematology, Molecular Biology and Surgery. According to data from OpenAlex, Pamela Bartels has authored 10 papers receiving a total of 740 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hematology, 3 papers in Molecular Biology and 2 papers in Surgery. Recurrent topics in Pamela Bartels's work include Acute Myeloid Leukemia Research (3 papers), Cancer therapeutics and mechanisms (2 papers) and Erythropoietin and Anemia Treatment (2 papers). Pamela Bartels is often cited by papers focused on Acute Myeloid Leukemia Research (3 papers), Cancer therapeutics and mechanisms (2 papers) and Erythropoietin and Anemia Treatment (2 papers). Pamela Bartels collaborates with scholars based in United States, Australia and Israel. Pamela Bartels's co-authors include William E. Fitzsimmons, Donna Przepiorka, Donald N. Buell, Chatchada Karanes, Stella M. Davies, Claudio Anasetti, Finn Bo Petersen, Belinda R. Avalos, Joseph W. Fay and Voravit Ratanatharathorn and has published in prestigious journals such as Journal of Clinical Oncology, Blood and American Heart Journal.

In The Last Decade

Pamela Bartels

10 papers receiving 729 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pamela Bartels United States 7 454 199 198 194 128 10 740
S Kulkarni United Kingdom 18 692 1.5× 129 0.6× 334 1.7× 256 1.3× 47 0.4× 32 810
Antònia Sampol Spain 14 430 0.9× 161 0.8× 189 1.0× 117 0.6× 31 0.2× 60 731
F. R. Appelbaum United States 14 552 1.2× 149 0.7× 287 1.4× 154 0.8× 31 0.2× 25 1.1k
P. Carlier Italy 17 534 1.2× 176 0.9× 177 0.9× 55 0.3× 23 0.2× 47 763
Alain Sadoun France 12 432 1.0× 142 0.7× 249 1.3× 131 0.7× 20 0.2× 28 820
Nicole A. Carreau United States 9 410 0.9× 73 0.4× 159 0.8× 157 0.8× 19 0.1× 12 677
Taner Demirer Türkiye 11 689 1.5× 132 0.7× 493 2.5× 74 0.4× 25 0.2× 22 976
Diane Warren United States 12 525 1.2× 214 1.1× 210 1.1× 348 1.8× 32 0.3× 40 1.0k
Anne Marie Maddox United States 12 124 0.3× 83 0.4× 125 0.6× 139 0.7× 57 0.4× 22 598
WJ Miller United States 12 1.0k 2.2× 312 1.6× 242 1.2× 272 1.4× 47 0.4× 19 1.4k

Countries citing papers authored by Pamela Bartels

Since Specialization
Citations

This map shows the geographic impact of Pamela Bartels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pamela Bartels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pamela Bartels more than expected).

Fields of papers citing papers by Pamela Bartels

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pamela Bartels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pamela Bartels. The network helps show where Pamela Bartels may publish in the future.

Co-authorship network of co-authors of Pamela Bartels

This figure shows the co-authorship network connecting the top 25 collaborators of Pamela Bartels. A scholar is included among the top collaborators of Pamela Bartels based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pamela Bartels. Pamela Bartels is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Henry, David H., John A. Glaspy, Rosemary Harrup, et al.. (2021). Roxadustat for the treatment of anemia in patients with lower‐risk myelodysplastic syndrome: Open‐label, dose‐selection, lead‐in stage of a phase 3 study. American Journal of Hematology. 97(2). 174–184. 42 indexed citations
2.
Henry, David H., John A. Glaspy, Rosemary Harrup, et al.. (2020). Oral Roxadustat Demonstrates Efficacy in Anemia Secondary to Lower-Risk Myelodysplastic Syndrome Irrespective of Ring Sideroblasts and Baseline Erythropoietin Levels. Blood. 136(Supplement 1). 29–30. 4 indexed citations
3.
Henry, David H., John A. Glaspy, Rosemary Harrup, et al.. (2019). Roxadustat (FG4592; ASP1517; AZD9941) in the Treatment of Anemia in Patients with Lower Risk Myelodysplastic Syndrome (LR-MDS) and Low Red Blood Cell (RBC) Transfusion Burden (LTB). Blood. 134(Supplement_1). 843–843. 16 indexed citations
4.
Tolcher, Anthony W., Alain C. Mita, Lionel D. Lewis, et al.. (2008). Phase I and Pharmacokinetic Study of YM155, a Small-Molecule Inhibitor of Survivin. Journal of Clinical Oncology. 26(32). 5198–5203. 208 indexed citations
5.
Alexandrescu, Doru T, Karl D. Lewis, Wolfram E. Samlowski, et al.. (2007). A phase II study of YM155 administered as 168 hour continuous infusion in stage IV and unresectable stage III melanoma.. Molecular Cancer Therapeutics. 6. 4 indexed citations
6.
Gonzalez, R., Karl D. Lewis, Wolfram E. Samlowski, et al.. (2007). A phase II study of YM155, a novel survivin suppressant, administered by 168 hour continuous infusion in patients with unresectable stage III or stage IV melanoma. Journal of Clinical Oncology. 25(18_suppl). 8538–8538. 6 indexed citations
7.
Papadopoulos, Kyriakos P., Alain C. Mita, Lionel D. Lewis, et al.. (2007). Efficacy and Safety of YM155 in Relapsed/Refractory Non-Hodgkin’s Lymphoma Patients Enrolled in a Phase I Study.. Blood. 110(11). 3422–3422. 2 indexed citations
8.
Nash, Richard A., Joseph H. Antin, Chatchada Karanes, et al.. (2000). Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors.. PubMed. 96(6). 2062–8. 426 indexed citations
9.
Horowitz, Mary M., Donna Przepiorka, Pamela Bartels, et al.. (1999). Tacrolimus vs. cyclosporine immunosuppression: Results in advanced-stage disease compared with historical controls treated exclusively with cyclosporine. Biology of Blood and Marrow Transplantation. 5(3). 180–186. 23 indexed citations
10.
Bartels, Pamela, et al.. (1988). Metastatic liposarcoma of the right ventricle with outflow tract obstruction: Restrictive pathophysiology predicts poor surgical outcome. American Heart Journal. 115(3). 696–698. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S Kulkarni Breakdown of academic impact, for papers by Antònia Sampol Breakdown of academic impact, for papers by F. R. Appelbaum Breakdown of academic impact, for papers by P. Carlier Breakdown of academic impact, for papers by Alain Sadoun Breakdown of academic impact, for papers by Nicole A. Carreau Breakdown of academic impact, for papers by Taner Demirer Breakdown of academic impact, for papers by Diane Warren Breakdown of academic impact, for papers by Anne Marie Maddox Breakdown of academic impact, for papers by WJ Miller
Rankless by CCL
2026